This photochemical process synthesizes α-arylglutarimides in glutarimides, suggesting new pathways for drug development.
Herein, we report a photochemical Ni-catalyzed cross-electrophile coupling of an α-mesylate glutarimide with aryl bromides to access 22 examples of α-arylglutarimides. Mechanistic insights allowed for the additional development of conditions that utilize a commercially available α-bromoglutarimide as a substitute for the α-mesylate glutarimide via a slow-addition protocol. These methods employ visible-light-driven metallaphotoredox catalysis to efficiently synthesize key scaffolds utilized in targeted protein degradation therapies.
No takes yet. Share an insight, caveat, or question.
Kuker et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: